<?xml version="1.0" encoding="UTF-8"?>
<p id="par0075">Recently published papers on treatment options and a list of drugs available have been reported recently in the literature to help with COVID-19 like antiviral drugs, anti-malaria and anti-inflammatory [
 <xref rid="bib0015" ref-type="bibr">3</xref>,
 <xref rid="bib0145" ref-type="bibr">[29]</xref>, 
 <xref rid="bib0150" ref-type="bibr">[30]</xref>, 
 <xref rid="bib0155" ref-type="bibr">[31]</xref>]. There are also publications, mainly from China and India [
 <xref rid="bib0015" ref-type="bibr">3</xref>], who recommended traditional medicinal plants to treat COVID-19. Several agents are being used under clinical trial and compassionate use protocols based on 
 <italic>in vitro</italic> activity (against COVID-19 or related viruses) and on limited clinical experience. Efficacy has not been established for any drug therapy. This list includes antimicrobials with potential activity against COVID-19: Chloroquine and Hydroxychloroquine both used – 
 <italic>In vitro</italic> and limited clinical data suggest potential benefit [
 <xref rid="bib0145" ref-type="bibr">29</xref>]. Other therapeutic drugs are Lopinavir; Remdesivir [
 <xref rid="bib0155" ref-type="bibr">31</xref>] and Favipiravir – their potential use is being studied. Azithromycin and Immunomodulating agents are used in some protocols based on theoretical mechanisms and limited preliminary data as adjunct therapy, COVID-19 convalescent plasma is also under investigation, NSAIDS –such as paracetamol and bronchodilators are as well in this list.
</p>
